AstraZeneca Articles
Stock Commentary - Europe - week to Feb 18, 2008
25 February 2008
Pinnacle and MedImmune sign Ethyol distribution deal
25 February 2008
Doctors claim statins cause memory loss
25 February 2008
Bentley's generic Losec wins European approval
18 February 2008
Stock Commentary - Europe - week to Feb 11, 2008
18 February 2008
AstraZeneca files for new Seroquel indication in EU
18 February 2008
Meditrina in deal with AstraZeneca
18 February 2008
Stock Commentary - Europe - week to Feb 4, 2008
11 February 2008
AstraZeneca's net profit falls 12% on restructing charges from MedImmune buy, lower Nexium sales
11 February 2008
Stock Commentary - Europe - week to Jan 28, 2008
4 February 2008
AstraZeneca 4th-qtr sales rise 8%
4 February 2008
Japan stock market week to Jan 28, 2008
4 February 2008
AstraZeneca's Seroquel cuts rate of mood events
4 February 2008
Stock Commentary - Europe - week to Jan 21, 2008
28 January 2008
Free lung cancer drugs donated in China
28 January 2008
Fostair launched in UK as cheaper than GSK/AZ asthma MDIs
28 January 2008
Pharma majors enter CSN experimental medicines consortium
28 January 2008
First treatment in Ph II CytoFab trial program
28 January 2008
AstraZeneca backs Shangahi Expo
28 January 2008
US clinic ships 19,000 drug firm gifts to Cameroon
28 January 2008
Kendle International hires Ross Horsburgh as VP of global clinical development, Asia-Pacific
21 January 2008
UPDATE: Raids on major drugmakers as EU Commission starts pharma sector inquiry with unannounced inspections
21 January 2008
Stock Commentary - Europe - week to Jan 14, 2008
21 January 2008
Crestor goes head to head with Lipitor
21 January 2008
Meta-analysis in The Lancet recommends statins for all diabetics, regardless of CV risk
21 January 2008
AZ files Seroquel XR for biopolar mania and depression
14 January 2008
Stock Commentary - Europe - week to Jan 7, 2008
14 January 2008
EFPIA announces animal test reduction
14 January 2008
PPI "overprescribing" costs UK's NHS L100M
14 January 2008
Patent expiry for 2008 provides generic opportunity
14 January 2008
AZD6244 falls short in Ph II skin cancer study
7 January 2008
UK's fraud probe of AZ and GSK deals in Iraq
7 January 2008
Sanofi-Aventis defers 2,600 medical rep job cuts
7 January 2008
EU parallel traders "legal action threat"
24 December 2007
AstraZeneca plans to partner more closely with pharmacy
24 December 2007
High dose Faslodex impresses in breast cancer trial
24 December 2007
Arimidex cuts breast cancer recurrence 24% vs tamoxifen
24 December 2007
Stock Commentary - Europe - week to Dec 10, 2007
17 December 2007
"No cardiac risks with AstraZeneca PPIs," FDA
17 December 2007
Inconclusive OFT report on UK DTP distribution
17 December 2007
UK's PMCPA names six firms in violation of Code
17 December 2007
UPDATE: MedImmune's biologics capabilities to boost AstraZeneca's flagging pipeline
17 December 2007
Chris Brinsmead named as ABPI president designate
10 December 2007
Seroquel impresses in MDD and GAD studies
10 December 2007
Stock Commentary - Europe - week to Dec 3, 2007
10 December 2007
KV reports record sales in 2nd-qtr fiscal 2008
10 December 2007
Pfizer looks to increase outsourcing to 30%
10 December 2007
AstraZeneca seeks 6% Japan market share
10 December 2007
Arimidex gets 6-month US patent extension
10 December 2007
Abraxis licenses Abraxane to Green Cross for Korea
3 December 2007
Stock Commentary - Europe - week to Nov 26, 2007
3 December 2007
Japan stock market week to Nov 26, 2007
3 December 2007
UPDATE: Sanofi-Aventis to invest 100 million euros in new Chinese flu vaccine facility
3 December 2007
Dosing begins in CAM-3001 RA trial
3 December 2007
EPO upholds AstraZeneca's MUPS PPI patents
26 November 2007
Japan stock market week to Nov 19, 2007
26 November 2007
Call for EU review of parallel trade by EAASM
26 November 2007
Sidem's PPI could have edge on nocturnal GERD
26 November 2007
FDA clears Seroquel XR as maintenance therapy
26 November 2007
Drug sales up 5% in year to September 2007
26 November 2007
Targacept gets $2M milestone from AZ
21 November 2007
US court doubles AZ and B-MS damages
21 November 2007
New appointments at MedImmune
19 November 2007
Reverse payment ban stalls in US Congress
19 November 2007
New indication in USA for AstraZeneca's Crestor
19 November 2007
Cobalt challenges Crestor patent
12 November 2007
AstraZeneca successfully prices L350M bond
12 November 2007
Stock Commentary - Europe - week to Nov 5, 2007
12 November 2007
AstraZeneca debuts Nexium savings prog
12 November 2007
Targacept gets $2M from AZ for CNS drug
12 November 2007
Crestor fails to reduce death in HF patients
12 November 2007
MedImmune selects second target under Seattle Genetics accord
5 November 2007
Stock Commentary - Europe - week to Oct 29, 2007
5 November 2007
Early RSV prevention offers economic benefits
5 November 2007
AstraZeneca integrates CAT and MedImmune
5 November 2007
FDA c'ttee recommends expanded indication for FluMist
29 October 2007
Stock Commentary - Europe - week to October 22, 2007
29 October 2007
Symbicort patent blow for AstraZeneca
29 October 2007
Japan stock market week to October 15, 2007
22 October 2007
Stock Commentary - Europe - week to October 15, 2007
22 October 2007
Review of the annual meeting of the ECNP
22 October 2007
Drug sales up 5% in year to August 2007
22 October 2007
Invega signficantly cuts schizophrenia vs Seroquel
22 October 2007
EPO rules Nexium process patent valid
15 October 2007
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
